CVS Health (CVS) is down 25% year-to-date and down 34% from its 52-week high. Brian Tanquilut discusses health care stocks and the outlook for pharmacy stocks. He talks about how Jefferies has a buy rating and a $110 price target on CVS. He goes over how CVS had to do two diluted acquisitions which impacted their stock. He also notes that CVS will see earnings pressure in the near-term. Tune in to find out more about the stock market today.
Morning Trade Live
23 Oct 2023
SHARE
Trading 360
28 Mar 2024
Morning Trade Live
28 Mar 2024
Morning Trade Live
16 Apr 2024
The Watch List
21 Feb 2024
Morning Trade Live
15 Apr 2024
Market On Close
10 Apr 2024